Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ovarian Neoplasms

Free Subscription Articles published in Am J Obstet Gynecol Retrieve available abstracts of 45 articles: HTML format

Single Articles

March 2024
1. LU J, Guo Q, Zhang Y, Zhao S, et al
   A modified diffusion-weighted MRI-based model from the radiologist's perspective: improved performance in determining the surgical resectability for advanced high-grade serous ovarian cancer.
   Am J Obstet Gynecol. 2024 Mar 1:S0002-9378(24)00415.
   PubMed     Abstract available
   
   
   September 2023
2. JONSSON S, Jonsson H, Lundin E, Haggstrom C, et al
   Pelvic inflammatory disease and risk of epithelial ovarian cancer. A national population-based case-control study in Sweden.
   Am J Obstet Gynecol. 2023 Sep 29:S0002-9378(23)00723.
   PubMed     Abstract available
   
   
   
3. LEE SS, Dinicu A, Arthurs L, Shileds D, et al
   Demographic reporting and language exclusion in gynecologic oncology clinical trials.
   Am J Obstet Gynecol. 2023 Sep 24:S0002-9378(23)00639.
   PubMed     Abstract available
   
   
   August 2023
4. ZHOU J, Wu P, Zhang Y
   Patient-reported quality of life might depend on prophylactic or therapeutic surgery for women with higher genetic predisposition to breast/ovarian cancer.
   Am J Obstet Gynecol. 2023 Aug 31:S0002-9378(23)00597.
   PubMed    
   
   
   
5. WEI X, Oxley S, Sideris M, Legood R, et al
   Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: Response.
   Am J Obstet Gynecol. 2023 Aug 31:S0002-9378(23)00598.
   PubMed    
   
   
   June 2023
6. BLUSTEIN P, Werner SR, Uppalapati P, Leung TM, et al
   Adherence to Risk-Reducing Salpingo-Oophorectomy Guidelines Among Gynecologic Oncologists Compared to General Gynecologists.
   Am J Obstet Gynecol. 2023 Jun 10:S0002-9378(23)00380.
   PubMed     Abstract available
   
   
   April 2023
7. GOMEZ SL, Mcguire V, Collin LJ, Dempsey L, et al
   Disparities in ovarian cancer survival: does place matter?
   Am J Obstet Gynecol. 2023 Apr 26:S0002-9378(23)00263.
   PubMed     Abstract available
   
   
   
8. WEI X, Oxley S, Sideris M, Kalra A, et al
   Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
   Am J Obstet Gynecol. 2023 Apr 12:S0002-9378(23)00240.
   PubMed     Abstract available
   
   
   
9. TERRA L, Beekman MJ, Engelhardt EG, Heemskerk-Gerritsen BAM, et al
   Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
   Am J Obstet Gynecol. 2023;228:440.
   PubMed     Abstract available
   
   
   March 2023
10. MINALT N, Caldwell A, Yedlicka GM, Joseph S, et al
    Association of Intrauterine Device Use and Endometrial, Cervical, and Ovarian Cancer: an Expert Review.
    Am J Obstet Gynecol. 2023 Mar 29:S0002-9378(23)00224.
    PubMed     Abstract available
    
    
    
11. FOSTER KI, Flores Legarreta A, Kamat R, Handley KF, et al
    Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
    Am J Obstet Gynecol. 2023 Mar 10:S0002-9378(23)00148.
    PubMed     Abstract available
    
    
    November 2022
12. CATHCART AM, Nezhat FR, Emerson J, Pejovic T, et al
    Adnexal masses during pregnancy: diagnosis, treatment and prognosis.
    Am J Obstet Gynecol. 2022 Nov 18:S0002-9378(22)02179.
    PubMed     Abstract available
    
    
    August 2022
13. BODURTHA SMITH AJ, Alvarez R, Heintz J, Haggerty A, et al
    Disparities in Biomarker Testing in Ovarian Cancer: A Real-World Analysis.
    Am J Obstet Gynecol. 2022 Aug 22. pii: S0002-9378(22)00686.
    PubMed    
    
    
    June 2022
14. MORUZZI MC, Bolomini G, Esposito R, Mascilini F, et al
    Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer.
    Am J Obstet Gynecol. 2022 Jun 22. pii: S0002-9378(22)00367.
    PubMed     Abstract available
    
    
    May 2022
15. CHAMBERS LM, O'Malley DM, Coleman RL, Herzog TJ, et al
    Is there a "Low Risk" Patient Population in Advanced Epithelial Ovarian Cancer?: A Critical Analysis.
    Am J Obstet Gynecol. 2022 May 28. pii: S0002-9378(22)00412.
    PubMed     Abstract available
    
    
    April 2022
16. HUEPENBECKER SP, Fu S, Sun CC, Zhao H, et al
    Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis.
    Am J Obstet Gynecol. 2022 Apr 29. pii: S0002-9378(22)00326.
    PubMed     Abstract available
    
    
    
17. ORLANDO MS, Cadish LA, Shepherd JP, Falcone T, et al
    Salpingo-Oophorectomy or Surveillance for Ovarian Endometrioma in Asymptomatic Premenopausal Women: a Cost-Effectiveness Analysis.
    Am J Obstet Gynecol. 2022 Apr 28. pii: S0002-9378(22)00324.
    PubMed     Abstract available
    
    
    
18. KARIA PS, Huang Y, Tehranifar P, Visvanathan K, et al
    Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
    Am J Obstet Gynecol. 2022 Apr 27. pii: S0002-9378(22)00317.
    PubMed     Abstract available
    
    
    
19. HUO N, Smith CY, Gazzuola Rocca L, Rocca WA, et al
    Risk of de novo cancer after premenopausal bilateral oophorectomy.
    Am J Obstet Gynecol. 2022;226:539.
    PubMed     Abstract available
    
    
    February 2022
20. MAI PL, Miller A, Black A, Falk RT, et al
    Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study.
    Am J Obstet Gynecol. 2022 Feb 22. pii: S0002-9378(22)00124.
    PubMed     Abstract available
    
    
    January 2022
21. XHOLLI A, Kratochwila C, Ferrero S, Moioli M, et al
    Role of three-dimensional ultrasound in ovarian cancer staging.
    Am J Obstet Gynecol. 2022 Jan 6. pii: S0002-9378(22)00001.
    PubMed    
    
    
    November 2021
22. SMITH MJ, Gerber D, Olsen A, Khouri OR, et al
    Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
    Am J Obstet Gynecol. 2021;225:508.
    PubMed     Abstract available
    
    
    
23. COREY L, Cote ML, Ruterbusch JJ, Winer I, et al
    Disparities in Adjuvant Treatment of High-Grade Endometrial Cancer in the Medicare Population.
    Am J Obstet Gynecol. 2021 Nov 1. pii: S0002-9378(21)01179.
    PubMed     Abstract available
    
    
    October 2021
24. CHI-HAU C
    Decidualized ovarian endometrioma.
    Am J Obstet Gynecol. 2021 Oct 7. pii: S0002-9378(21)01104.
    PubMed    
    
    
    
25. MANDELBAUM RS, Matsuzaki S, Sangara RN, Klar M, et al
    Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
    Am J Obstet Gynecol. 2021;225:399.
    PubMed     Abstract available
    
    
    September 2021
26. CUSIMANO MC, Ferguson SE, Moineddin R, Chiu M, et al
    Ovarian Cancer Incidence and Death in Average-Risk Women Undergoing Bilateral Salpingo-Oophorectomy at Benign Hysterectomy.
    Am J Obstet Gynecol. 2021 Sep 23. pii: S0002-9378(21)01048.
    PubMed     Abstract available
    
    
    
27. VAN LIESHOUT LAM, Gelderblom ME, DE Hullu JA, The R, et al
    Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy.
    Am J Obstet Gynecol. 2021 Sep 15. pii: S0002-9378(21)01007.
    PubMed     Abstract available
    
    
    June 2021
28. MARCHAND G, Mills K, Ware K
    Reply to a question regarding ovarian cancer prevention with partial salpingectomy versus complete.
    Am J Obstet Gynecol. 2021 Jun 30. pii: S0002-9378(21)00769.
    PubMed    
    
    
    May 2021
29. MARCHOCKI Z, Cusimano MC, Clarfield L, Rachel Kim S, et al
    Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
    Am J Obstet Gynecol. 2021 May 28. pii: S0002-9378(21)00602.
    PubMed     Abstract available
    
    
    
30. VAN WEELDEN WJ, Lalisang RI, Bulten J, Lindemann K, et al
    IMPACT OF HORMONAL BIOMARKERS ON RESPONSE TO HORMONAL THERAPY IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER.
    Am J Obstet Gynecol. 2021 May 18. pii: S0002-9378(21)00554.
    PubMed     Abstract available
    
    
    
31. SUH-BURGMANN E, Brasic N, Jha P, Hung YY, et al
    Ultrasound characteristics of early stage high-grade serous ovarian cancer.
    Am J Obstet Gynecol. 2021 May 13. pii: S0002-9378(21)00551.
    PubMed     Abstract available
    
    
    March 2021
32. NAUMANN RW, Hughes BN, Brown J, Drury LK, et al
    The Impact of Opportunistic Salpingectomy on Ovarian Cancer Mortality and Healthcare Costs: A Call For Universal Insurance Coverage.
    Am J Obstet Gynecol. 2021 Mar 30. pii: S0002-9378(21)00212.
    PubMed     Abstract available
    
    
    February 2021
33. HARRISON RF, Fu S, Sun CC, Zhao H, et al
    Patient cost-sharing during poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer.
    Am J Obstet Gynecol. 2021 Feb 4. pii: S0002-9378(21)00086.
    PubMed     Abstract available
    
    
    January 2021
34. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    PubMed     Abstract available
    
    
    
35. MATSUO K, Mandelbaum RS, Matsuzaki S, Klar M, et al
    Ovarian conservation for young women with early-stage low-grade endometrial cancer: A proposal for a two-step approach.
    Am J Obstet Gynecol. 2021 Jan 4. pii: S0002-9378(20)32630.
    PubMed     Abstract available
    
    
    December 2020
36. MASCIULLO V, Trivellizzi N, Zannoni G, Catena U, et al
    Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Am J Obstet Gynecol. 2020 Dec 29. pii: S0002-9378(20)32627.
    PubMed     Abstract available
    
    
    August 2020
37. SAMIMI G, Sathyamoorthy N, Tingen CM, Mazloomdoost D, et al
    Report of NCI and NICHD-Sponsored Workshop: Gynecology and Women's Health-Benign Conditions and Cancer.
    Am J Obstet Gynecol. 2020 Aug 21. pii: S0002-9378(20)30877.
    PubMed     Abstract available
    
    
    
38. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    PubMed     Abstract available
    
    
    
39. ALBRIGHT BB, Nasioudis D, Craig S, Moss HA, et al
    Impact of Medicaid expansion on women with gynecologic cancer: A difference-in-difference analysis.
    Am J Obstet Gynecol. 2020 Aug 7. pii: S0002-9378(20)30835.
    PubMed     Abstract available
    
    
    July 2020
40. PADILLA-ISERTE P, Lago V, Tauste C, DIaz-Feijoo B, et al
    Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
    Am J Obstet Gynecol. 2020 Jul 18. pii: S0002-9378(20)30744.
    PubMed     Abstract available
    
    
    
41. FERRARI F, Forte S, Sbalzer N, Zizioli V, et al
    Validation of an enhanced recovery after surgery protocol in gynecological surgery: an Italian randomized study.
    Am J Obstet Gynecol. 2020 Jul 8. pii: S0002-9378(20)30720.
    PubMed     Abstract available
    
    
    May 2020
42. CHAMBERS LM, Morton M, Lampert E, Yao M, et al
    Use of Prophylactic Closed Incision Negative Pressure Therapy Is Associated with Reduced Surgical Site Infections in Gynecologic Oncology Patients Undergoing Laparotomy.
    Am J Obstet Gynecol. 2020 May 14. pii: S0002-9378(20)30536.
    PubMed     Abstract available
    
    
    April 2020
43. MANDELBAUM RS, Adams CL, Yoshihara K, Nusbaum DJ, et al
    The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecological disease in the United States.
    Am J Obstet Gynecol. 2020 Apr 30. pii: S0002-9378(20)30514.
    PubMed     Abstract available
    
    
    March 2020
44. MILLER H, Matsuo K
    A cesarean delivery sequela: Scar rupture and tumor spill during laparoscopic hysterectomy for endometrial cancer.
    Am J Obstet Gynecol. 2020 Mar 18. pii: S0002-9378(20)30337.
    PubMed    
    
    
    
45. KASPERS M, Llamocca E, Quick A, Dholakia J, et al
    Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment.
    Am J Obstet Gynecol. 2020 Mar 3. pii: S0002-9378(20)30232.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.